BIIB (BIIB) Stock Price & Analysis
BIIB (BIIB) fell 1.64% to USD 220.83 as of September 8, 2026 at 02:51 UTC, according to Nexqual real-time market data.
BIIB last closed at USD 220.83; the session ranged USD 219.82–223.78 on volume of 465,108 shares. Market capitalization is —, with a 52-week range of USD 135.39–225.8 (NMS). Source: Nexqual, September 8, 2026 at 02:51 UTC.
Key Statistics (as of September 8, 2026 at 02:51 UTC)
| Price | USD 220.83 |
|---|---|
| Change | ▼ 1.64% (down) |
| Previous Close | USD 220.83 |
| Open | USD 220.83 |
| Day Range | USD 219.82 – 223.78 |
| 52-Week Range | USD 135.39 – 225.8 |
| Volume | 465,108 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BIIB)
Nexqual's technical model rates BIIB "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 02:51 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.68 (neutral) |
| vs SMA50 | Above (USD 209.53) |
| MACD | 4.04 (positive) |
From BIIB's Latest SEC 10-K Filing (filed 2026-02-06)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | USD 827.72 | ▼ 2.85% |
| AMGN | Amgen Inc. | USD 437.23 | ▼ 1.27% |
| GILD | Gilead Sciences, Inc. | USD 151 | ▲ 0.93% |
| VRTX | Vertex Pharmaceuticals Incorpor | USD 546.12 | ▼ 1.91% |
| ILMN | Illumina, Inc. | USD 218.22 | ▲ 2.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 02:51 UTC. This page is informational and not investment advice.